Answers are grounded in this paper and cite their sources.
Aim In this study, we compared the outcome of cataract extraction in patients with juvenile idiopathic arthritis (JIA)-associated uveitis treated with adalimumab (ADA) compared to patients treated with infliximab (IFX). Patients and methods The study included 22 eyes of 22 children with JIA-associated chronic anterior uveitis. The ADA group included 16 patients while the IFX group included six patients. All patients underwent irrigation/aspiration without intraocular lens implantation. The data were collected retrospectively before and 6 months after surgery including best corrected visual acuity (BCVA), intraocular pressure, slit lamp biomicroscopy, and fundus examination. All eyes included in the study had completely inactive intraocular inflammation for 3 months before surgery. The change in BCVA was the main outcome measure. Results The two groups were age and sex matched. In the ADA group, there was a statistically significant improvement in the mean LogMAR BCVA from 1.063±0.33 preoperatively to 0.538±0.54 postoperatively ( P =0.0085), while in the IFX group the mean BCVA improved from 1.183±0.475 preoperatively to 0.683±0.594 postoperatively, with no statistically significant difference ( P =0.068). The difference in the postoperative BCVA between the two groups was not statistically significant ( P =0.68). A larger percentage of patients in the IFX group developed postoperative inflammation (33.3 vs. 25%). Conclusion The visual acuity improved after cataract extraction in patients with JIA-associated uveitis treated with ADA or IFX, but the improvement was more significant in the patients treated with ADA.
No takes yet. Share an insight, caveat, or question.
Fadel et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: